Stockreport

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations [Yahoo! Finance]

Navidea Biopharmaceuticals, Inc.  (NAVB) 
NASDAQ:AMEX Investor Relations: ir.navidea.com
PDF The company maintains strategic focus on its Fix, Fund, Propel approach. COLUMBUS, Ohio, January 27, 2024 BUSINESS WIRE )--Navidea Biopharmaceuticals, Inc. (OTC: NAVB) [Read more]